4Travis LB,Fossa SD,Schonfeld SJ,et al.Second cancers among 40,576 testicular cancer patients:focus on longterm survivors[J].J Natl Cancer Inst,2005,97(18):1354-1365.
5Mauch PM,Kalish LA,Marcus KC,et al.Long-term survival in Hodgkinr s disease relative impact of mortality,second tumors,infection,and cardiovascular disease[J].Cancer J Sci Am,2006,1(1):33-42.
6Curtis RE,Ron E,Ries LAG,et al.New Malignancies A-mong Cancer Survivors:SEER Cancer Registries,1973-2000[M].Bethesda,MD:National Institutes of Health,2006:397-441.
7Thomas A,Mailankody S? Korde N,et al.Second malignancies after multiple myeloma:from 1960s to 2010s[J].Blood,2012,119(12):2731-2737.
8Bergsagel DE,Bailey AJ,Langley GR,et al.The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia[J].N Engl J Med,1979,301(14);743-748.
9Greene MH,Harris EL,Gershenson DM?et al.Melphalan May be a more potent leukemogen than cyclophosphamide[J],Ann Intern Med,1986,105(3):360-367.
10Pedersen-Bjergaard J,Ersboll J,Sorensen HM,et al.Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas.Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents[J].Ann Intern Med,1985,103(2):195-200.
5KOBAYASHI Y,NAKAYAMA M,UEMURA N.Analysis of myelodysplastic syndrome clones arising after multiple myeloma:a case study by correlative interphase cytogenetic analysis[J].Japanese J Clin Oncol,1999,29:374-377.
6Natazuka T,Yamaguchi T, Murayama T,et al. Chronic myelomono- cytic leukemia following prolonged alkylating agent therapy for multiple myeloma [ J ]. Int J Hematol,1994,60 (4) :263--265.
7Xu Y, McKenna RW, Karandikar NJ,et al. Flow cytometric analy- sis of monocytes as a tool for distinguishing chronic myelomono- cytic leukemia from reactive monocytosis [ J]. Am J Clin Pathol , 2005,124 ( 5 ) :799 - 806.
8Kojima H , Bai A, Mukai HY, et al. Chronic myelomonocytic leukemia derived from a possible common progenitor of mono- cytes and natural killer cells [ J ] . Leuk Lymphoma,2000,37 (5/ 6) :617-621.
9Habashi HM, Sharp RA, Pippard MJ. Multiple myeloma and chro- nic myelomonocytic leukemia developing in a patient with autoim- mune disease [J] . J Int Med,1991,230 ( 4 ) :361 -362.
10Bear MR, Stewart CC, Lawrence D,et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8 ;21 ) [J]. Blood,1997,90(4) :1643 - 1648.
